CClinicalTrials.gg
CompletedNCT03487692MESSAGESUpdated Nov 3, 2022

Medical Care, Education, Social Support, And Goal-setting to Empower Self-management for Diabetes

An interventional study of Diabetes MESSAGES Program and Diabetes MESSAGES Program (second trial) in Type 2 Diabetes Mellitus, sponsored by University of Chicago. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-11-03.

Sponsored by University of Chicago · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
265
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Diabetes group visits, shared appointments where patients receive self-management education in a group setting and have a medical visit, are a promising way to deliver high quality diabetes care. Group visits can improve glycemic control and decrease healthcare utilization. To date, no studies have systematically implemented a diabetes group visit intervention in a network of U.S. community health centers. The University of Chicago is partnering with Midwest Clinicians' Network (MWCN), a member organization of 130 health centers across ten Midwestern states. Approximately half of all Federally Qualified Health Centers in this region are affiliated with MWCN. The objectives of the study are [1] providers and staff at 20 health centers will have the requisite knowledge, skills, and motivation to implement a diabetes group visit plus text messaging intervention at their sites; [2] changes in diabetes processes of care; knowledge, attitudes, and skills for diabetes self-management; clinical outcomes; and health care utilization for patients participating in the diabetes group visit program will be evaluated; and [3] the diabetes group visit program will be available for dissemination among and use by health centers and healthcare providers at the local, state, regional, and national levels.

Read the detailed description

UChicago and MWCN will recruit and enroll 20 health centers (HCs) to participate in a training intervention and to implement diabetes group visit and text messaging programs at their clinic sites. Each HC will assemble a team of 3-4 providers and staff to participate in the training. HCs will be randomized to one of two training cohorts. HC providers and staff will attend two in-person Learning Sessions in Chicago and a series of monthly webinars, recruit and enroll patients, implement a 6-month diabetes group visit and text messaging program plus subsequent booster sessions, complete periodic surveys and interviews, assist with data collection through patient surveys and chart abstraction, and present their program to peer HCs during Learning Sessions and to local stakeholders, state primary care organizations, or other professional groups. Each HC will enroll 15 patients in the group visit and text messaging program; the 2018 Training Cohort will do so immediately following their enrollment in the study and the 2020 Training Cohort will do so after 18 months. During the first 18 months, the 2020 Training Cohort will collect data from electronic health records (EHR) of randomly selected patients to serve as a control group. Changes in self-reported outcomes, diabetes processes of care, and clinical outcomes will be assessed for intervention patients from baseline through 2 year follow up, and processes of care and clinical outcomes will be compared for intervention vs. control participants. Capacity of HC providers and staff to conduct a group visit and text messaging intervention for patients with diabetes, as well as their confidence in identifying and addressing health disparities, will be evaluated through surveys and in-depth interviews. This study will expand knowledge of the barriers, facilitators, and perceived benefits and drawbacks of group visit and text messaging interventions and inform the development of a toolkit that will be disseminated to other HCs.

02

Conditions studied

  • Type 2 Diabetes Mellitus

Keywords

  • diabetes
  • group visit
  • shared medical appointment
  • text messaging
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 18 years or older
  • diagnosis of type 2 diabetes
  • attended at least two appointments at the HC within the past year, with at least one of them being during the past six months
  • last documented A1c result greater than or equal to 8.0% (test must have been done during the last 6 months)
  • own a cellular phone with text messaging capabilities
  • have the ability to read and send text messages
  • English or Spanish speaking

Exclusion criteria

Exclusion Criteria:

  • pregnant or planning to become pregnant
  • uncontrolled psychiatric problem
  • dementia or other cognitive impairment
  • hearing difficulties or severe physical disability that would prevent them from participation in group visit
  • planning to relocate in the next year or leave the area during the group visit period
04

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
265 participants (actual)

Study arms

  • Experimental
    2018 Training Cohort

    10 health centers will be randomized to the 2018 Training Cohort. Teams from these health centers will be trained and will implement a 6 month diabetes group visit and text messaging intervention (Diabetes MESSAGES Program).

    Other: Diabetes MESSAGES Program

  • Other
    2020 Training Cohort

    10 health centers will be randomized to the 2020 Training Cohort. Prior to beginning training, these health centers will collect data on randomly selected patients receiving usual care to serve as the control group. After this first parallel group trial period, teams from these health centers will be trained and will implement the 6 month diabetes group visit and text messaging intervention during a second single group trial period (Diabetes MESSAGES Program (second trial)).

    Other: Diabetes MESSAGES Program (second trial)

Interventions

  • OtherDiabetes MESSAGES Program

    Health centers in the 2018 Training Cohort will enroll groups of 10-15 patients to attend 6 monthly diabetes group visits consisting of group education, social support, goal setting, and an individual medical visit for each patient. At the same time, patients will be enrolled in a 6-month interactive diabetes text messaging program. Patients will receive quarterly booster sessions for 1-2 years after the 6-month intervention period.

  • OtherDiabetes MESSAGES Program (second trial)

    During the first trial period, health centers in the 2020 Training Cohort will collect data on patients receiving usual care. After the first trial period, health centers in the 2020 Training Cohort will enroll groups of 10-15 patients to attend 6 monthly diabetes group visits consisting of group education, social support, goal setting, and an individual medical visit for each patient. At the same time, patients will be enrolled in a 6-month interactive diabetes text messaging program. Patients will receive quarterly booster sessions for 1-2 years after the 6-month intervention period.

05

What researchers measure

Primary outcomes

  1. Hemoglobin A1C

    Time frame: change from baseline to 12 months

Secondary outcomes

  1. Hemoglobin A1C

    Time frame: baseline, 6 month, and 18 month for intervention vs. control patients; 30 month for intervention patients only

  2. Blood pressure

    Time frame: baseline, 6 month, and 18 month for intervention vs. control patients; 30 month for intervention patients only

  3. Weight

    Time frame: baseline, 6 month, and 18 month for intervention vs. control patients; 30 month for intervention patients only

  4. Cholesterol

    Time frame: baseline, 6 month, and 18 month for intervention vs. control patients; 30 month for intervention patients only

  5. Diabetes processes of care

    Receipt of recommended screenings, exams, referrals, and vaccinations

    Time frame: baseline, 6 month, and 18 month for intervention vs. control patients; 30 month for intervention patients only

  6. Medication management of diabetes

    changes in prescribed diabetes medications for patients with inadequate diabetes control

    Time frame: baseline, 6 month, and 18 month for intervention vs. control patients; 30 month for intervention patients only

  7. Number of hypoglycemic events

    Time frame: baseline, 6 month, and 12 month for intervention patients only

  8. Number of hospital admissions

    Time frame: baseline, 6 month, and 18 month for intervention vs. control patients; 30 month for intervention patients only

  9. Number of primary care, specialist, and ER visits

    Time frame: baseline, 6 month, and 18 month for intervention vs. control patients; 30 month for intervention patients only

  10. Smoking status

    Time frame: baseline, 6 month, and 12 month for intervention patients only

  11. Health related quality of life (SF-12)

    Time frame: baseline, 6 month, and 12 month for intervention patients only

  12. Depression (PHQ-2)

    Time frame: baseline, 6 month, and 12 month for intervention patients only

  13. Summary of Diabetes Self-Care Activities Measure

    Time frame: baseline, 6 month, and 12 month for intervention patients only

  14. Understanding of Diabetes Self-Management (Diabetes Care Profile)

    Time frame: baseline, 6 month, and 12 month for intervention patients only

  15. Attitudes Towards Diabetes (Diabetes Care Profile)

    Time frame: baseline, 6 month, and 12 month for intervention patients only

  16. Diabetes Distress Scale (DDS-2)

    Time frame: baseline, 6 month, and 12 month for intervention patients only

  17. Diabetes Quality of Life Scale

    Time frame: baseline, 6 month, and 12 month for intervention patients only

  18. Diabetes Self-Empowerment Scale

    Time frame: baseline, 6 month, and 12 month for intervention patients only

  19. Diabetes Social Support Scale

    Time frame: baseline, 6 month, and 12 month for intervention patients only

  20. Patient satisfaction with intervention

    Time frame: 6 month and 12 month for intervention patients only

  21. CAHPS Overall Rating

    Patient satisfaction with overall care at health center

    Time frame: baseline, 6 month, and 12 month for intervention patients only

  22. CAHPS Cultural Competency

    Patient satisfaction with cultural competency of care at health center

    Time frame: baseline, 6 month, and 12 month for intervention patients only

  23. CAHPS Provider Communication

    Patient satisfaction with provider communication at health center

    Time frame: baseline, 6 month, and 12 month for intervention patients only

Other outcomes

  1. Patient engagement

    Attendance/participation in group visits, text messaging, and booster sessions

    Time frame: through study completion, an average of 2 years

  2. Health center provider/staff preparedness

    Capacity, confidence, motivation, perceived benefits and barriers

    Time frame: change from pre- to post-training (from baseline to 1 month, 7 month, and 16 month)

  3. Health center provider/staff satisfaction

    Satisfaction with training, group visits, and text messaging

    Time frame: post-training (16 month)

06

Study locations

1 site
  • University of Chicago
    Chicago, Illinois 60637, United States
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03487692
Lead sponsor
University of Chicago
Collaborators
Midwest Clinicians' Network, CareMessage
Responsible party
Sponsor
First posted
Apr 4, 2018
Start date
Oct 18, 2018
Primary completion
May 15, 2022
Completion
Jun 30, 2022
Last update
Nov 3, 2022

Study contacts

Arshiya Baig, MD, MPH
principal investigator · University of Chicago

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion